Mu opioid receptor gene polymorphism and neuroleptic-induced tardive dyskinesia in patients with schizophrenia

Schizophr Res. 2003 Dec 1;65(1):61-3. doi: 10.1016/s0920-9964(02)00491-7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Chronic Disease
  • Dose-Response Relationship, Drug
  • Dyskinesia, Drug-Induced / diagnosis
  • Dyskinesia, Drug-Induced / genetics*
  • Gene Frequency / genetics
  • Genotype
  • Humans
  • Long-Term Care
  • Neurologic Examination
  • Polymorphism, Genetic / genetics*
  • Receptors, Opioid, mu / genetics*
  • Risk Factors
  • Schizophrenia / drug therapy
  • Schizophrenia / genetics*

Substances

  • Antipsychotic Agents
  • Receptors, Opioid, mu